Opharm E-comm Spółka z Ograniczoną Odpowiedzialnością (KRS 0000899504, NIP 5070097763) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. OPHARM E-COMM operates in: Retail sale via mail order houses or via Internet (PKD 47.91.Z). Industry: Retail trade. The company has been listed in the National Court Register since May 12, 2021. OPHARM E-COMM's most recently reported net revenue was 1.5 M PLN for 2023.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Opharm E-comm
Identity
- Name
- Opharm E-comm Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- May 12, 2021
- Registry status as of
- January 24, 2026
- Latest entry
- January 23, 2026
- Founding act
- 13.01.2025 R., REP. A NUMER 107/2025, AKT NOTARIALNY Z DNIA 13 STYCZNIA 2025 R.SPORZĄDZONY PRZEZ NOTARIUSZA EDYTĘ GRABOW…
Articles of association history (2)
- 27 KWIETNIA 2021 R., NOTARIUSZ W ŁODZI EDYTA GRABOWSKA, REP. 1743/2021.
- January 13, 2025: 13.01.2025 R., REP. A NUMER 107/2025, AKT NOTARIALNY Z DNIA 13 STYCZNIA 2025 R.SPORZĄDZONY PRZEZ NOTARIUSZA EDYTĘ GRABOWSKĄ, KANCELARIA NOTARIALNA W ŁODZI (90-003) UL. JULIANA TUWIMA 6 - ZMIENIONO § 3 UMOWY SPÓŁKI ORAZ PRZYJĘTO NOWY TEKST JEDNOLITY UMOWY SPÓŁKI
Activities
Main activity
47.91.ZRetail sale via mail order houses or via Internet
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. OMŁOTOWA, 23, 94-251, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-10295-55644-CSDTD-31
- Coordinates
- 51.7768, 19.4547approx.
Risk and payment profile - Opharm E-comm
Credibility rating
18.5 / 100
Very poor credibility
Insolvency risk
Moderate
Significant formal threat
Closure risk
43
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
2
2/5 yrs
Board changes
1
1/5 yrs
PKD changes
0
0/5 yrs
Name changes
0
0/5 yrs
Data from 5 years of registry activity.
Credibility history
Payment reliability score from 2021–2023
Current: E (19/100)
Trend: deteriorating (-17.6 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2021–2023
Current: 18.1 K PLN
Safe: 3.1 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Opharm E-comm
Founded
May 12, 2021
5 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
47.91.Z
Retail sale via mail order houses or via Internet
Share capital
5.0 K PLN
100 shares total
Shareholders
1
shareholder
Board
1 person
Proxies: 1
Filed years
3 years
2021–2023 · profitable: 2/3
Registry entries
19
latest: January 23, 2026
Risk signals
Revenue
1.5 M PLN
2023
Net profit
-118.8 K PLN
2023
Assets
816.2 K PLN
2023
Equity
118.8 K PLN
2023
EBITDA
-102.1 K PLN
2023
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Opharm E-comm.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1 m capex (+212%), PLN 1.10 dividend three years running, Cydr Lubelski plus Romanian Zarea as the premium engine
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
